FEMY today
$1.40-$0.10 (-6.67%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourAscending Triangle
15 minExpanding
5 minStrong Bullish
Daily trend turns up above $1.53
Key levels
Resistance$2.02
Resistance$1.53
Support$1.25
Latest news & SEC filings
SEC FilingFemasys Inc filed an insider trading report (Form 4)
NewsFemasys Announces Changes to Its Board of Directors
SEC FilingFemasys Inc filed a report on a major company event (Form 8-K)
All FEMY news →About Femasys
Femasys is a biomedical company that develops in-office therapeutic and diagnostic devices for women's health. Its products include FemaSeed for intratubal insemination, FemVue and FemChec for fallopian tube evaluation, FemCerv for cervical tissue sampling, and FemBloc, a non-surgical permanent birth control system in late-stage clinical development. The company sells to gynecologists and fertility practices in the United States and through distribution partners in Europe, the UK, Canada, Israel, Australia, New Zealand, and Japan.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
FEMASYS INC (FEMY)
What Is the Price Target for FEMY?
SEPT Low Target
$10.00
SEPT Mid Target
$10.00
SEPT High Target
$10.00
Analyst Consensus
$10.00
Is FEMY a Buy or Sell Right Now?
Thesis
- •Revenue growing 40.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for FEMY.
Start Free Trial →Is FEMY Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
PEG, Analyst Consensus
Fair Value
$6.37
15
Moat Score
NONE
3/9
Piotroski Score
-9.7
Altman Z-Score
What Is Smart Money Doing with FEMY?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →FEMY Growth Story
Revenue YoY
40.8%
3yr Revenue CAGR
23.9%
EPS Growth YoY
44.71%
FCF Growth YoY
4.9%
Revenue Trend
ACCELERATING
Dark Pool Trades for FEMY
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for FEMY, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:25:58 | $1.44 | 1,100 | $$2K | MIDPOINT |
| 20:16:33 | $1.42 | 9,180 | $$13K | SELL |
| 20:16:33 | $1.42 | 1,020 | $$1K | SELL |
| 20:15:17 | $1.48 | 2,000 | $$3K | MIDPOINT |
| 17:14:41 | $1.52 | 3,000 | $$5K | BUY |
5 dark pool trades shown · $$24K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for FEMASYS INC (FEMY) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →FEMY — frequently asked questions
What is FEMY stock price today?
FEMASYS INC (FEMY) is at $1.40, down 6.67% (-$0.10) at the Nov 12, 2026 close.
Why is FEMY stock moving today?
Latest FEMY news — Nov 5, 2026: Femasys Inc filed an insider trading report (Form 4) · Nov 3, 2026: Femasys Announces Changes to Its Board of Directors
What is the FEMY price target?
The average analyst price target for FEMY is $10.00, ranging from $10 to $10, based on 1 analysts. Latest: Maxim Group maintains on Aug 14, 2026.
What do analysts rate FEMY?
Analyst ratings for FEMY: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did FEMY beat earnings?
FEMY last reported on Aug 14, 2026: EPS -$1.33 vs -$1.31 expected — a miss of 1.5%.
What is FEMY's P/E ratio?
FEMY trades at a P/E of 0.9 vs a Healthcare average of 17.7.
Does FEMY pay a dividend?
FEMY does not currently pay a dividend.
What are FEMY support and resistance levels?
Support: $1.25. Resistance: $1.53, $2.02, $2.27.
What are insiders doing with FEMY?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on FEMY?
Nov 5, 2026: Femasys Inc filed an insider trading report (Form 4) · Nov 3, 2026: Femasys Announces Changes to Its Board of Directors · Nov 2, 2026: Femasys Inc filed a report on a major company event (Form 8-K)